Targeted plasmid integration into the Human Genome by engineered recombinases

Published

Journal Article

The targeted integration of transgenes into cellular genomes is central to numerous applications in biotechnology, basic science, and medicine. In recent years, a variety of advances have improved upon conventional methods for site-specific transgene integration. Most of these methods involve nucleases that cleave DNA to activate DNA repair pathways including homologous recombination or integrases that fully catalyze the integration reaction but are limited in their capacity to target new sites in the genome. Recently, zinc-finger recombinases have emerged as a class of engineered enzymes that combines the strengths of both of these previous methods. Zinc-finger recombinases can fully and autonomously catalyze plasmid integration into the genome of mammalian cells without creating free DNA breaks. In addition, they can be engineered to target new genomic recognition sites by exchanging the modular and programmable DNA-binding domain and through directed evolution of the serine recombinase catalytic domain. This chapter reviews the development of the zinc-finger recombinase technology, including discussions of its strengths and weaknesses and the future directions necessary to translate this technology into routine use for transgene integration into cellular genomes. © 2013 Springer Science+Business Media B.V.

Full Text

Duke Authors

Cited Authors

  • Gersbach, CA; Barbas, CF

Published Date

  • January 1, 2013

Published In

Volume / Issue

  • 23 /

Start / End Page

  • 267 - 284

Electronic International Standard Serial Number (EISSN)

  • 1610-6970

International Standard Serial Number (ISSN)

  • 1610-2096

Digital Object Identifier (DOI)

  • 10.1007/978-94-007-4531-5_10

Citation Source

  • Scopus